Combination Products

Standalone Module - Spring 2027 - 3 ETCS - CHF 3'150

  

Combination products include a combination of a medical device, and a drug (and/or biologic – only US). This module aims to provide participants with knowledge of the regulatory requirements for each component of a combination product including their similarities and differences. It will additionally provide participants with an understanding of combination product market launch considerations.  

Learning objectives

  • You understand the definitions in the EU and the US and familiarizes with the regulatory frameworks,
  • You understand regulatory requirements for each component of a combination product including their similarities and differences,
  • You understand use cases of combination products (e.g. diagnostic or therapeutic),
  • You understand the types and use cases of Combination Products,
  • You understand important standards and guidelines,
  • You know how to categorize and distinguish different medical device software (e.g. standalone, embedded, accessory, etc.) familiar with new regulatory developments (e.g., AI Act EU),
  • You are sensitized to moral and ethical issues (algorithm bias, representative data, hallucination, etc.),
  • You know how to apply transition timelines in EU,
  • You know how to structure technical documentation (eCTD vs. MDR Annex II, STED, ToC, etc.)

Scope & duration

3 ECTS points
This is equivalent to roughly 75-90 working hours

Start

The module takes place in spring term each year.

📍On-site events take place at sitem-insel in Bern, Switzerland.

Please feel free to contact the School if you have any more detailed questions.

Fee

This module can be attended as single course at a fee of CHF 3'150.-
👉 Contact the School if you are interested in this module as a single course.

Founder, Chairman and CEO of confinis AG (Switzerland and USA)

Beat U. Steffen

Beat Steffen, RAC, FRAPS, Founder, Chairman & CEO of confinis AG, (Switzerland and USA) holds a MSc in electrical engineering an executive MBA and has 25+ years of experience in medical device and combination product development/manufacturing/quality management/regulatory affairs. He founded confinis ag in 2005 and co-founded Medical Human Factors AG in 2016, a company specialized in evaluating the use-related safety, effectiveness and usability of medical products.

Global Head Regulatory Medical Devices, Combination Products & Precision Medicine at Novartis

Mike Wallenstein

Mike Wallenstein Global Head Regulatory Medical Devices, Combination Products & Precision Medicine at Novartis has more than 25 years of experience in various aspects of the MedTech industry.